You are here: Industry Insights > Allergan

News List

AbbVie to Buy Allergan for $63B contractpharma
June 26, 2019
As Humira faces competition, diversifies portfolio with biggest name in medical aesthetics.
Amgen and Allergan secure US FDA approval for Herceptin biosimilar pharmaceutical-technology
June 19, 2019
The US Food and Drug Administration (FDA) has approved Amgen and Allergan’s Kanjinti (trastuzumab-anns).
Allergan and Gedeon Richter Receive U.S. FDA Approval For Expanded Use of Vraylar (cariprazine) in the Treatment of Bipolar Depression drugs
May 29, 2019
Allergan and Gedeon Richter Receive U.S. FDA Approval For Expanded Use of Vraylar (cariprazine) in the Treatment of Bipolar Depression.
Allergan, Gedeon Richter Receive FDA Approval for Expanded Use of VRAYLAR® for Bipolar Depression americanpharmaceuticalreview
May 29, 2019
Allergan and Gedeon Richter announced the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for VRAYLAR® (cariprazine) for expanded use to treat depressive episodes associated with bipolar I disorder (bipolar
Allergan puts Vraylar on blockbuster track with new bipolar depression nod fiercepharma
May 29, 2019
Allergan, badly in need of good news, finally has some to share with investors.
Allergan and Ironwood's IBS-C push links patients to telemedicine fiercepharma
May 09, 2019
The “Oh My Gut!” effort highlights the multiple symptoms of irritable bowel syndrome with constipation—and aims to ease the path to diagnosis.
Allergan's new concierge platform Regi finds medical aesthetic and spa treatments fiercepharma
April 21, 2019
Regi—short for regimen—is Allergan’s first-ever digital booking platform for aesthetic treatments.
Allergan and Molecular Partners Announce Topline Safety Results from MAPLE study of Abicipar pegol April 03, 2019
Allergan plc,, a leading global pharmaceutical company and Molecular Partners, a clinical-stage biotechnology company developing a new class of drugs known as DARPin® therapies, today announced topline safety results from MAPLE...
Activist investor Appaloosa dismisses Allergan board promises as "meaningless" firstwordpharma
March 26, 2019
Hedge fund Appaloosa, which has been urging Allergan to separate the roles of chairman and chief executive, is brushing aside the drugmaker's recent disclosure that it plans to make the split ……
FDA expands label for Allergan’s antibacterial Avycaz By Allie Nawrat pharmaceutical-technology
March 20, 2019
FDA expands label for Allergan's Avycaz to include children with cIAI's and cUTI's. Credit: Shutterstock.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page